Viva Biotech Holdings (FRA:VB0)
0.2000
-0.0080 (-3.85%)
At close: Jan 20, 2026
Viva Biotech Holdings Revenue
Viva Biotech Holdings had revenue of 831.87M CNY in the half year ending June 30, 2025, a decrease of -27.17%. This brings the company's revenue in the last twelve months to 1.84B, down -7.94% year-over-year. In the year 2024, Viva Biotech Holdings had annual revenue of 1.99B, down -7.84%.
Revenue (ttm)
1.84B CNY
Revenue Growth
-7.94%
P/S Ratio
2.67
Revenue / Employee
880.91K CNY
Employees
2,085
Market Cap
582.24M EUR
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.99B | -168.93M | -7.84% |
| Dec 31, 2023 | 2.16B | -224.05M | -9.42% |
| Dec 31, 2022 | 2.38B | 275.55M | 13.10% |
| Dec 31, 2021 | 2.10B | 1.41B | 201.90% |
| Dec 31, 2020 | 696.96M | 373.90M | 115.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Paul Hartmann AG | 2.44B |
| FRoSTA Aktiengesellschaft | 652.00M |
| Maschinenfabrik Berthold Hermle AG | 469.42M |
| Südwestdeutsche Salzwerke AG | 347.96M |
| EUROKAI GmbH & Co. KGaA | 262.47M |
| Northern Data AG | 200.27M |
| Berliner Effektengesellschaft AG | 174.56M |
| Novabase S.G.P.S. | 130.35M |